GlassScriptPhysician profile
Margaret Ting Ryan
NPI 1093926560
$5,562.67
in general payments reported to CMS, 2019-2025
50 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $320 · 2021: $280 · 2022: $1,453 · 2023: $755 · 2024: $770 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,624.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $902.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $485.76 | 2019-2025 | Evenity, Tepezza, Prolia |
| Novo Nordisk INC | $391.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.49 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $264.36 | 2019-2025 | |
| Abbvie INC. | $262.09 | 2019-2025 | Synthroid |
| Astrazeneca Pharmaceuticals LP | $214.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $200.82 | 2021-2024 | |
| Radius Health, INC. | $166.65 | 2019-2025 | Tymlos, Binosto |
| Kyowa Kirin, INC. | $156.18 | 2023-2025 | Crysvita |
| Abbott Laboratories | $153.60 | 2022-2023 | Freestyle Libre 3 |
| Dexcom, INC. | $144.47 | 2020-2023 | Dexcom G6 Transmitter |
| Madrigal Pharmaceuticals | $141.16 | 2025 | Rezdiffra |
| Xeris Pharmaceuticals, INC. | $133.50 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Corcept Therapeutics | $115.98 | 2022-2025 | Korlym |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.